• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    DNA Sequencing Market Research Report - Forecast to 2032 Infographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    DNA Sequencing Market

    ID: MRFR/LS/4319-HCR
    90 Pages
    Rahul Gotadki
    September 2025

    DNA Sequencing Market Research Report Information By Product (Consumable, Instrument, and Service), By Application (Diagnostics, Biomarkers & Cancer, Reproductive Health, Personalized Medicine, and Forensics), By Technology (Semiconductor Sequencing, Sequencing by Ligation, and Pyrosequencing), By End-User (Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, and Hospitals & Clinics), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    DNA Sequencing Market Research Report - Forecast to 2032 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License

    DNA Sequencing Market Summary

    As per Market Research Future Analysis, the DNA Sequencing Market was valued at USD 13.46 billion in 2023 and is projected to reach USD 46.85 billion by 2032, growing at a CAGR of 12.97% from 2024 to 2032. Key drivers include advancements in sequencing technology, increased applications in personalized medicine, and rising demand for genomic research. The market is segmented into consumables, instruments, and services, with consumables holding the largest share. Applications span diagnostics, oncology, and forensics, with significant growth expected in personalized medicine. North America leads the market, followed by Europe and Asia-Pacific, with notable investments in R&D and technological advancements fueling growth.

    Key Market Trends & Highlights

    The DNA Sequencing Market is witnessing significant growth driven by technological advancements and increased applications.

    • Market Size in 2023: USD 13.46 billion; projected to reach USD 46.85 billion by 2032.
    • CAGR of 12.97% during the forecast period (2024-2032).
    • North America accounted for USD 1.05 billion in 2022, leading the market share.
    • Biomarkers & cancer applications hold a considerable market share, driven by rising cancer prevalence.

    Market Size & Forecast

    2023 Market Size USD 13.46 billion
    2024 Market Size USD 15.63 billion
    2032 Market Size USD 46.85 billion
    CAGR 12.97% (2024-2032)

    Major Players

    Key players include Illumina, Inc., Roche, Thermo Fisher Scientific, QIAGEN, and Pacific Biosciences.

    DNA Sequencing Market Trends

      • Increased technological advancement to boost the market growth

    DNA sequencing technology can sequence multiple DNA strands through massive parallelization. Such sequencing includes Sanger sequencing and non-Sanger sequencing. Compared with microarrays and other genomic analysis methods, DNA sequencing has the advantages of low cost, high accuracy, high speed, and precise results, even with small sample input volumes. DNA sequencing is used to perform a variety of applications, such as biomarker discovery, oncology research, personalized medicine, forensics, and more. It simplifies nucleotide analysis and is a broad alternative to traditional genomics tools, notably microarrays, genotyping, and more.

    The demand for DNA sequencing has increased significantly owing to the proliferation of sequencing applications and the increase in technological advancements in DNA sequencing. Moreover, the surge in genome mapping initiatives and increasing investment in research and development across the globe drive market growth.

    DNA sequencing has brought about a paradigm shift in proteomics and genomics research. It is a highly accurate and high-throughput technology used in various applications such as de novo assembly, WGS, and DNA resequencing. Therefore, the technology is quickly adopted by several academic research institutions for research. Illumina installed the NovaSeq 6000 Sequencing System at the Whitehead Biomedical Research Institute in Massachusetts, USA, in June 2020.

    The market of DNA sequencing is driven by efforts by the Centers for Medicare & Medicaid Services (CMS), the Society for Molecular Pathology, and commercial payers such as Blue Cross Blue Shield and Aetna to facilitate the clinical use of sequencing technology. For example, in January 2020, China Medical System expanded the coverage of NGS-based diagnostic tests for ovarian and breast cancer patients, providing patients with more opportunities for personalized cancer care. Therefore, the market CAGR of DNA Sequencing has been increasing globally in recent years. These are essential factors driving the DNA Sequencing market revenue growth.

     

    The sequencing of DNA is a method that uses extensive parallelization to sequence many DNA strands. Both Sanger's technique and non-Sanger methods of sequencing are used in this sequencing. The development of pharmacological treatments for cancer is accelerated by individualized targeted sequencing of tumors, which also discovers cancer targets or pathways. Introducing large-scale initiatives utilizing NGS techniques produces a fresh fundamental understanding of oncology precision therapy. Compared to microarray and other genetic analysis methods, DNA sequencing offers advantages such as excellent accuracy & speed, cheap cost, and accurate results even with limited sample input.

    Biomarker identification, forensic analysis, oncology research, and individualized healthcare are among the uses for DNA sequencing.

    It has greatly outperformed more traditional genomics methods, including genotyping, microarray, and others, and has sped up the study of nucleotides. DNA sequencing, a highly accurate and high-throughput technology utilized for various applications, including WGS, de novo assembly, and DNA resequencing, has caused an upheaval in proteomic and genomic studies. As a result, several academic research institutions can utilize this technology for research investigations. Consumer call for DNA sequencing has significantly increased due to the surge in sequencing applications and growth in DNA sequencing technology. Additionally, a boost in worldwide genome mapping efforts and R&D spending drive the market's expansion.

    Technology advancements in DNA sequencing, increased clinical diagnostics and drug development applications, and higher R&D spending influence market growth. Applications for DNA sequencing can be found in forensics, personalized medicine, biomarkers, reproductive health, and other fields. DNA sequencing technology has enormous potential in clinical research and development for cancer diagnostics and therapies. The ability of NGS, or next-generation sequencing, to find and characterize clinically relevant genetic variations across several genes in a single test has recently been established quickly and affordably.

    In June 2024: Roche announced a strategic partnership with a leading bioinformatics company to enhance DNA sequencing data analysis capabilities.

    In November 2023, Illumina, Inc. unveiled its Global Health Access Initiative to improve the access to sequencing tools used in public health by poor nations. PacBio has entered into an agreement to acquire Apton Biosystems by August 2023. The takeover is expected to fasten short-read sequencer development, prompting the market growth

    The ongoing advancements in DNA sequencing technologies are poised to revolutionize personalized medicine, enhancing diagnostic capabilities and treatment options across various healthcare sectors.

    U.S. National Institutes of Health (NIH)

    DNA Sequencing Market Drivers

    Rising Demand for Personalized Medicine

    The Global DNA Sequencing Market Industry experiences a notable surge in demand for personalized medicine, driven by advancements in genomics and biotechnology. As healthcare shifts towards tailored treatments, DNA sequencing plays a pivotal role in identifying genetic variations that influence drug responses. This trend is underscored by the projected market value of 15.6 USD Billion in 2024, reflecting the growing integration of genomic data in clinical practices. Furthermore, the increasing prevalence of genetic disorders necessitates precise diagnostic tools, thereby propelling the adoption of DNA sequencing technologies. The emphasis on personalized healthcare solutions is likely to sustain growth in the Global DNA Sequencing Market Industry.

    Market Segment Insights

    DNA Sequencing Product Insights

    Based on Product, the market segments of DNA Sequencing includes Consumables, Instruments, and Service. The consumable segment held the majority share in 2022, contributing most of the DNA Sequencing market revenue. The wide availability of reagents and kits for all library construction steps, such as DNA fragmentation, enrichment, adapter ligation, amplification, and quality control, contributes to a larger share of this segment. Most of these tools feature streamlined and simplified workflows, ready-to-use components, and compatibility with low-input and formalin-fixed specimens.

    The continuous availability and availability of reagents and kits have made WGS more accessible and affordable, driving the market of DNA sequencing.

    DNA Sequencing Application Insights

    Application has bifurcated the DNA Sequencing market data into diagnostics, biomarkers & cancer, reproductive health, personalized medicine, and forensics. Biomarkers & cancer have a considerable share of the market. The market is expected to grow over the forecast year owing to the increasing prevalence of cancer and advancements in next-generation sequencing technologies. However, the personalized medicine segment is expected to witness considerable growth in the next-generation sequencing market over the forecast period owing to surging demand for drug treatments, advancements in research and development in healthcare, and rising awareness of NGS testing in the pharmaceutical and biotechnology industries.

    DNA Sequencing Technology Insights

    The DNA Sequencing market segmentation has been divided based on Technology into Semiconductor Sequencing, Sequencing by Ligation, and Pyrosequencing. Sequencing by ligation accounted for the largest market share of the DNA Sequencing due to the widespread use of DNA sequencing platforms in sequencing scenarios. It is likely to continue to dominate throughout the forecast period.

    DNA Sequencing End-User Insights

    Based on End-User, the DNA Sequencing industry has been segmented into academic & government research institutes, pharmaceutical companies, biotechnology companies, and hospitals & clinics. The academic & government research institute segment is expected to contribute a higher market share due to the wide acceptance of Sanger techniques and NGS in academic and institutional research projects. Moreover, rising funding and investment plans increase these entities' demand for DNA sequencing products, leading to a more significant revenue share.

    Figure 1 DNA Sequencing Market by End-User, 2022 & 2030 (USD billion)

    Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

    News: The most current findings come from the prospective research GEMINI, or Genomic Medicine in Ill Infants and Newborns, in which four hundred hospitalized newborns had their complete genomes sequenced and underwent targeted gene panel testing. Even though it took longer, whole-genome sequencing beat the targeted test at identifying the origin of an infant's symptoms, with a diagnosis rate of 49% as opposed to 27% for the smaller panel. One-fifth of the individuals saw modifications to their treatment, such as medical professionals choosing to use or forgo specific medications and surgical treatments.

    Get more detailed insights about DNA Sequencing Market Research Report - Forecast to 2032

    Request Free Sample

    Regional Insights

    By Region, the study provides market insights into North America, Europe, Asia-Pacific, and Rest of the World. North American DNA Sequencing market, which accounted for USD 1.05 billion in 2022, is expected to exhibit a significant CAGR growth during the study period. Continuous technological development by major players, high investment in R&D, and availability of technologically advanced healthcare infrastructure have led North America to hold a leading market share in the DNA sequencing. Several government initiatives in the United States and Canada support drug development and cancer treatment research.

    Further, the significant countries studied in the market report are The U.S., Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

    Figure 3 DNA SEQUENCING MARKET SHARE BY REGION 2023 (%)DNA SEQUENCING MARKET SHARE BY REGION 2022

    Source Secondary Research, Primary Research, MRFR Database, and Analyst Review

    Europe's DNA Sequencing market accounts for the second-largest market share. Increasing adoption of organic growth strategies, such as product launches by key players in the Region to expand product portfolios, is expected to drive market growth over the forecast period. For example, in December 2021, Swiss-based pharmaceutical company F. Hoffmann-La Roche Ltd announced the launch of the AVENIO Edge System to provide a fully automated, integrated sequencing solution. The AVENIO Edge System is a pre-analytical platform for sequencing library preparation, target enrichment, and quantification steps that provides integrated end-to-end control and reliable, consistently high-quality results.

    Further, the German market of DNA Sequencing held the largest market share, and the U.K. market of DNA Sequencing was the fastest-growing market in the European Region.

    The Asia-Pacific DNA Sequencing Market is expected to grow at the fastest CAGR from 2024 to 2032. A growing customer base drives international companies to expand their business through strategic moves. A prominent California company has raised over $75 million to expand its desktop DNA sequencers to support the ongoing crisis of COVID-19. Moreover, the China market of DNA Sequencing held the largest market share, and the Indian market of DNA Sequencing was the fastest-growing market in the Asia-Pacific region.

    Key Players and Competitive Insights

    Major market players are spending a lot on R&D to increase their product lines, which will help the market of DNA Sequencing grow even more. Market participants are also taking various strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. Competitors in the DNA Sequencing industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

    Manufacturing locally to reduce operating costs is one of the primary business strategies manufacturers adopt in the DNA Sequencing industry to benefit clients and expand the market sector. The DNA Sequencing industry has provided medicine with some of the most significant benefits in recent years. In the market of DNA Sequencing, major players such as Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative Inc., and others are working on expanding the market demand by investing in research and development activities.

    Illumina, Inc. is an American biotechnology company headquartered in San Diego, California, serving over 140 countries. Illumina was founded on April 1, 1998, to develop, manufacture, and sell integrated systems to analyze genetic variation and biological function. The company offers a range of products and services for sequencing, genotyping, gene expression, and proteomics. On January 9, 2023, pharmaceutical company Illumina Inc. and Nashville Biosciences LLC, a wholly owned Vanderbilt University Medical Center (VUMC) subsidiary, announced an agreement with biopharmaceutical company Amgen to sequence the whole genome of DNA samples of approximately 35,000 samples.

    The protocol helps accelerate therapeutic development through genomics and builds superior clinical genomic datasets.

    Also, F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational healthcare company with two divisions Pharmaceuticals and Diagnostics. The shares of its holding company, Roche Holding AG, are listed on the six major Swiss exchanges. The company is headquartered in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the world's leading provider of cancer treatments. In May 2020, F. Hoffman-La Roche Ltd. announced the acquisition of Stratos Genomics to advance the development of Roche nanopore sequencers. Roche believes the acquisition helps address clinical research needs and, thus, patient needs.

    Key Companies in the DNA Sequencing Market market include

    Industry Developments

    • Q2 2024: Illumina to spin off Grail after antitrust pressure Illumina announced it will divest cancer detection company Grail following a lengthy antitrust battle with U.S. and European regulators, marking a major shift in the DNA sequencing sector.
    • Q2 2024: PacBio Launches Revio 2.0, a New High-Throughput Sequencing System Pacific Biosciences (PacBio) unveiled the Revio 2.0, a next-generation sequencing platform designed to deliver higher throughput and lower costs for whole-genome sequencing applications.
    • Q2 2024: Oxford Nanopore Technologies and NVIDIA Announce Strategic Partnership for AI-Driven Genomics Oxford Nanopore Technologies entered a partnership with NVIDIA to integrate AI-powered analytics into its DNA sequencing platforms, aiming to accelerate genomic data interpretation.
    • Q1 2024: Element Biosciences Raises $277 Million in Series C Funding Element Biosciences, a developer of DNA sequencing technology, secured $277 million in Series C funding to expand commercialization of its AVITI sequencing platform.
    • Q2 2024: Thermo Fisher Scientific Receives FDA Clearance for Next-Generation Sequencing-Based Test Thermo Fisher Scientific announced FDA clearance for its Oncomine Dx Express Test, a next-generation sequencing assay for solid tumor profiling in cancer diagnostics.
    • Q1 2024: Roche Acquires Stratos Genomics to Advance DNA Sequencing Technology Roche completed the acquisition of Stratos Genomics, a company specializing in nanopore-based sequencing, to enhance its portfolio of next-generation sequencing solutions.
    • Q2 2024: Illumina Appoints Jacob Thaysen as Chief Executive Officer Illumina announced the appointment of Jacob Thaysen as its new CEO, signaling a leadership change at the DNA sequencing giant.
    • Q1 2024: Ultima Genomics Raises $100 Million to Scale Ultra-Low-Cost Sequencing Platform Ultima Genomics raised $100 million in new funding to accelerate the commercialization of its high-throughput, low-cost DNA sequencing technology.
    • Q2 2024: BGI Genomics Opens New Sequencing Facility in Singapore BGI Genomics inaugurated a new high-capacity DNA sequencing facility in Singapore to serve the Asia-Pacific region and expand its global footprint.
    • Q1 2024: Singular Genomics Systems Announces Initial Public Offering Singular Genomics Systems filed for an IPO on the NASDAQ, aiming to raise capital for the development and commercialization of its next-generation sequencing platforms.
    • Q2 2024: Qiagen and BioNTech Announce Collaboration on Personalized Cancer Sequencing Qiagen and BioNTech entered a strategic collaboration to develop and commercialize next-generation sequencing solutions for personalized cancer immunotherapy.
    • Q1 2024: Agilent Technologies Launches New Target Enrichment Solution for NGS Agilent Technologies introduced a new SureSelect target enrichment product designed to improve the efficiency and accuracy of next-generation DNA sequencing workflows.

    Future Outlook

    DNA Sequencing Market Future Outlook

    The Global DNA Sequencing Market is projected to grow at a 14.23% CAGR from 2024 to 2035, driven by advancements in technology, increasing demand for personalized medicine, and rising genomic research funding.

    New opportunities lie in:

    • Develop targeted sequencing solutions for rare diseases to capture niche markets.
    • Invest in AI-driven analytics platforms to enhance data interpretation efficiency.
    • Expand partnerships with biotech firms to accelerate product development and market entry.

    By 2035, the DNA Sequencing Market is expected to be a pivotal component of healthcare innovation and research.

    Market Segmentation

    DNA Sequencing Product Outlook

    • Consumable
    • Instrument
    • Service

    DNA Sequencing End-User Outlook

    • Academic & Government Research Institutes
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Hospitals & Clinics

    DNA Sequencing Regional Outlook

    North America
    • US
    • Canada

    DNA Sequencing Technology Outlook

    • Semiconductor Sequencing
    • Sequencing by Ligation
    • Pyrosequencing

    DNA Sequencing Application Outlook

    • Diagnostics
    • Biomarkers & Cancer
    • Reproductive Health
    • Personalized Medicine
    • Forensics

    Report Scope

    Report Attribute/Metric Details
    Market Size 2023 USD 13.46 billion
    Market Size 2024 USD 15.63billion
    Market Size 2032 USD 46.85 billion
    Compound Annual Growth Rate (CAGR) 12.97% (2024-2032)
    Base Year 2023
    Market Forecast Period 2024-2032
    Historical Data 2019 - 2021
    Market Forecast Units Value (USD Billion)
    Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
    Segments Covered Product, Application, Technology, End-User, and Region
    Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
    Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
    Key Companies Profiled Agilent Technologies Inc., Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies Ltd., Macrogen Inc., Perkin Elmer Inc., Pacific Biosciences of California Inc., BGI.
    Key Market Opportunities New product launches and R&D Amongst major key Players.
    Key Market Dynamics Growing requirement of breeders for animals and plant production Development in technology It is increasing research and development.

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    How much is the DNA sequencing market?

    The DNA sequencing market size was valued at USD 13.46 Billion in 2023.

    What is the growth rate of the DNA sequencing market?

    The market is projected to grow at a CAGR of 12.97% during the forecast period, 2024-2032.

    Which Region held the largest market share in the DNA sequencing market?

    North America had the largest share of the market.

    Who are the key players in the DNA sequencing market?

    The key players in the market are Agilent Technologies Inc., Thermo Fisher Scientific Inc., Illumina Inc., QIAGEN, and F. Hoffmann-La Roche Ltd.

    Which Product led the DNA sequencing market?

    The consumable DNA sequencing category dominated the market in 2023.

    Which Application had the largest market share in the DNA sequencing market?

    Biomarkers & cancer had the largest share of the market.

    1. Chapter 1. DNA Sequencing System Market Report
    2. Prologue
    3. Chapter 2. DNA Sequencing System Market Introduction
      1. Definition
      2. Scope of the Study
        1. Research Objective
        2. Assumptions
        3. Limitations
    4. Chapter 3. Research Methodology
      1. Introduction
      2. Primary Research
      3. Secondary Research
      4. Market Size Estimation
    5. Chapter 4. DNA Sequencing System Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
      5. Macroeconomic Indicators
    6. Technology Trends & Assessment
    7. Chapter 5. DNA Sequencing System Market Factor Analysis
      1. Porter’s Five Forces Analysis
        1. Bargaining
    8. Power of Suppliers
      1. Bargaining Power of Buyers
        1. Threat of New
    9. Entrants
      1. Threat of Substitutes
        1. Intensity of Rivalry
    10. Value Chain Analysis
      1. Investment Feasibility Analysis
      2. Pricing Analysis
    11. Chapter 6. Global DNA Sequencing System Market, by Type
      1. Introduction
      2. Instruments and Consumables
    12. Market Estimates & Forecast, by Region,
    13. Market Estimates & Forecast, by Country, 2023-2030
      1. Services
    14. Market Estimates & Forecast, by Region, 2023-2030
    15. Market Estimates &
    16. Forecast, by Country, 2023-2030
      1. Workflow Products
    17. Market Estimates
    18. & Forecast, by Region, 2023-2030
    19. Market Estimates & Forecast, by Country,
    20. Chapter 7. Global DNA Sequencing System Market, by Product
    21. Introduction
      1. Systematic Antibiotics
      2. Sequencing services
    22. Market
    23. Estimates & Forecast, by Region, 2023-2030
    24. Market Estimates & Forecast,
    25. by Country, 2023-2030
      1. Sequencing instruments and consumables
    26. Market
    27. Estimates & Forecast, by Region, 2023-2030
    28. Market Estimates & Forecast,
    29. by Country, 2023-2030
      1. Sequencing instruments and consumables by product
    30. type
    31. Market Estimates & Forecast, by Region, 2023-2030
    32. Market Estimates
    33. & Forecast, by Country, 2023-2030
      1. Consumables
    34. Market Estimates
    35. & Forecast, by Region, 2023-2030
    36. Market Estimates & Forecast, by Country,
      1. Instruments
    37. Market Estimates & Forecast, by Region,
    38. Market Estimates & Forecast, by Country, 2023-2030
    39. Sequencing instruments and consumables by platform
    40. Market Estimates & Forecast,
    41. by Region, 2023-2030
    42. Market Estimates & Forecast, by Country, 2023-2030
      1. NGS
    43. Market Estimates & Forecast, by Region, 2023-2030
    44. Market
    45. Estimates & Forecast, by Country, 2023-2030
      1. Sanger
    46. Market
    47. Estimates & Forecast, by Region, 2023-2030
    48. Market Estimates & Forecast,
    49. by Country, 2023-2030
      1. Bioinformatics
    50. Market Estimates & Forecast,
    51. by Region, 2023-2030
    52. Market Estimates & Forecast, by Country, 2023-2030
      1. Sample prep kits and reagents
    53. Market Estimates & Forecast, by
    54. Region, 2023-2030
    55. Market Estimates & Forecast, by Country, 2023-2030
    56. Chapter 8. Global DNA Sequencing System Market, by Technology
      1. Introduction
      2. Semiconductor sequencing
    57. Market Estimates & Forecast, by Region,
    58. Market Estimates & Forecast, by Country, 2023-2030
      1. Pyrosequencing
    59. Market Estimates & Forecast, by Region, 2023-2030
    60. Market Estimates &
    61. Forecast, by Country, 2023-2030
      1. Sequencing by synthesis
    62. Market Estimates
    63. & Forecast, by Region, 2023-2030
    64. Market Estimates & Forecast, by Country,
      1. Single-molecule real-time sequencing (SMRT)
    65. Market Estimates
    66. & Forecast, by Region, 2023-2030
    67. Market Estimates & Forecast, by Country,
      1. Sequencing by ligation (SBL)
    68. Market Estimates & Forecast,
    69. by Region, 2023-2030
    70. Market Estimates & Forecast, by Country, 2023-2030
      1. Other technologies
    71. Market Estimates & Forecast, by Region, 2023-2030
    72. Market Estimates & Forecast, by Country, 2023-2030
    73. Chapter 9. Global
    74. DNA Sequencing System Market, by Application
      1. Introduction
      2. Diagnostics
    75. Market Estimates & Forecast, by Region, 2023-2030
    76. Market Estimates &
    77. Forecast, by Country, 2023-2030
      1. Agriculture & animal research
    78. Market
    79. Estimates & Forecast, by Region, 2023-2030
    80. Market Estimates & Forecast,
    81. by Country, 2023-2030
      1. Biomarker discovery
    82. Market Estimates & Forecast,
    83. by Region, 2023-2030
    84. Market Estimates & Forecast, by Country, 2023-2030
      1. Personalized medicine
    85. Market Estimates & Forecast, by Region, 2023-2030
    86. Market Estimates & Forecast, by Country, 2023-2030
      1. Drug discovery
    87. Market Estimates & Forecast, by Region, 2023-2030
    88. Market Estimates &
    89. Forecast, by Country, 2023-2030
      1. Other applications
    90. Market Estimates
    91. & Forecast, by Region, 2023-2030
    92. Market Estimates & Forecast, by Country,
    93. Chapter 10. Global DNA Sequencing System Market, by End-Users
      1. Introduction
      2. Research centres and government institutes & academia
    94. Market Estimates & Forecast, by Region, 2023-2030
    95. Market Estimates &
    96. Forecast, by Country, 2023-2030
      1. Biotechnology & Pharmaceutical companies
    97. Market Estimates & Forecast, by Region, 2023-2030
    98. Market Estimates &
    99. Forecast, by Country, 2023-2030
      1. Clinics & Hospitals
    100. Market Estimates
    101. & Forecast, by Region, 2023-2030
    102. Market Estimates & Forecast, by Country,
      1. Other end-users
    103. Market Estimates & Forecast, by Region,
    104. Market Estimates & Forecast, by Country, 2023-2030
    105. Chapter
    106. Global DNA Sequencing System Market, by Region
      1. Introduction
    107. America
      1. North America
        1. US
    108. South America
      1. Europe
        1. Western Europe
    109. Rest of Western Europe
      1. Eastern Europe
      2. Asia-Pacific
    110. Japan
      1. China
        1. India
        2. Australia
        3. South
    111. Korea
      1. Rest of Asia-Pacific
      2. Middle East & Africa
    112. Middle East
      1. Africa
    113. Chapter 12. DNA Sequencing System Market Company
    114. Landscape
      1. Introduction
      2. Market Share Analysis
      3. Key Development
    115. & Strategies
    116. Chapter 13. Company Profiles
      1. Perkin Elmer
    117. Company Overview
      1. Product Overview
        1. Financials Overview
        2. Key Developments
        3. SWOT Analysis
      2. Roche Holdings AG
        1. Company Overview
        2. Product Overview
        3. Financial Overview
        4. Key Developments
        5. SWOT Analysis
      3. Siemens AG
    118. Company Overview
      1. Product Overview
        1. Financial Overview
        2. Key Development
        3. SWOT Analysis
      2. Illumina
    119. Company Overview
      1. Product Overview
        1. Financial Overview
        2. Key Development
        3. SWOT Analysis
      2. Agilent Technologies
    120. Inc
      1. Company Overview
        1. Product Overview
        2. Financial
    121. overview
      1. Key Developments
        1. SWOT Analysis
      2. Genia
    122. Corporation
      1. Company Overview
        1. Product Overview
    123. Financial Overview
      1. Key Developments
        1. SWOT Analysis
    124. Oxford Nanopore technologies
      1. Overview
        1. Product Overview
        2. Financial Overview
        3. Key Developments
        4. SWOT Analysis
    125. 8 Koninklijke Philips N.V.
      1. Overview
        1. Product Overview
        2. Financials
        3. Key Developments
        4. SWOT Analysis
    126. Pacific Biosciences
      1. Overview
        1. Product Overview
    127. Financials
      1. Key Developments
        1. SWOT Analysis
      2. Johnson
    128. & Johnson
      1. Overview
        1. Product Overview
        2. Financials
        3. Key Developments
        4. SWOT Analysis
      2. Deep Genomics,
    129. Inc
      1. Overview
        1. Product Overview
        2. Financials
        3. Key Developments
        4. SWOT Analysis
      2. Life Technologies
        1. Overview
        2. Product Overview
        3. Financials
    130. Key Developments
      1. SWOT Analysis
    131. 13 Eppendorf
    132. 13.1Overview
    133. 13.2Product Overview
    134. 13.3Financials
    135. 13.4Key Developments
    136. 13.5SWOT Analysis
    137. 14 Tecan
    138. 14.1Overview
    139. 14.2Product
    140. Overview
    141. 14.3Financials
    142. 14.4Key Developments
    143. 14.5SWOT
    144. Analysis
    145. 15 Hamilton Thorne Biosciences
    146. 15.1Overview
      1. Product Overview
    147. 15.3Financials
    148. 15.4Key Developments
      1. SWOT Analysis
    149. 16 General Electric Company
      1. Overview
        1. Product
    150. Overview
      1. Financials
        1. Key Developments
        2. SWOT Analysis
    151. 17 Siemens Healthineers GmbH
      1. Overview
        1. Product Overview
        2. Financials
        3. Key Developments
        4. SWOT Analysis
    152. Myriad Genetics
      1. Overview
        1. Product Overview
        2. Financials
        3. Key Developments
        4. SWOT Analysis
      2. Bayer Corporation
        1. Overview
        2. Product Overview
        3. Financials
        4. Key
    153. Developments
      1. SWOT Analysis
      2. Beckman Coulter
        1. Overview
        2. Product Overview
        3. Financials
        4. Key Developments
        5. SWOT Analysis
      3. Thermo Scientific
        1. Overview
        2. Product
    154. Overview
      1. Financials
        1. Key Developments
        2. SWOT Analysis
    155. Chapter 14 MRFR Conclusion
      1. Key Findings
        1. From CEO’s
    156. Viewpoint
      1. Unmet Needs of the Market
      2. Key Companies to Watch
      3. Predictions for the Global DNA Sequencing Industry
    157. Chapter 15. Appendix
    158. Synopsis, 2023-2030
    159. Forecast, 2023-2030 (USD Million)
    160. by Types, 2023-2030 (USD Million)
    161. by Product, 2023-2030 (USD Million)
    162. by Technology, 2023-2030 (USD Million)
    163. Market, by Application, 2023-2030 (USD Million)
    164. System Market, by End-User, 2023-2030 (USD Million)
    165. System Market, by Region, 2023-2030(USD Million)
    166. Sequencing System Market, by Types, 2023-2030 (USD Million)
    167. America: DNA Sequencing System Market, by Product, 2023-2030 (USD Million)
    168. North America: DNA Sequencing Market, by Technology, 2023-2030 (USD Million)
    169. Million)
    170. (USD Million)
    171. (USD Million)
    172. Million)
    173. US: DNA Sequencing Market, by Region, 2023-2030 (USD Million)
    174. DNA Sequencing Market, by Types, 2023-2030 (USD Million)
    175. Sequencing Market, by Product, 2023-2030 (USD Million)
    176. Sequencing Market, by Technology, 2023-2030 (USD Million)
    177. DNA Sequencing Market, by Application, 2023-2030 (USD Million)
    178. DNA Sequencing Market, by End-User, 2023-2030 (USD Million)
    179. DNA Sequencing Market, by Region, 2023-2030 (USD Million)
    180. DNA Sequencing Market, by Types, 2023-2030 (USD Million)
    181. DNA Sequencing Market, by Product, 2023-2030 (USD Million)
    182. DNA Sequencing Market, by Technology, 2023-2030 (USD Million)
    183. America: DNA Sequencing Market, by Application, 2023-2030 (USD Million)
    184. South America: DNA Sequencing Market, by End-User, 2023-2030 (USD Million)
    185. Europe: DNA Sequencing Market, by Product, 2023-2030 (USD Million)
    186. Europe: DNA Sequencing Market, by Technology, 2023-2030 (USD Million)
    187. Europe: DNA Sequencing Market, by Application, 2023-2030 (USD Million)
    188. Europe: DNA Sequencing Market, by End-User, 2023-2030 (USD Million)
    189. Europe: DNA Sequencing Market, by Region, 2023-2030 (USD Million)
    190. Western Europe: DNA Sequencing Market, by Types, 2023-2030 (USD Million)
    191. Western Europe: DNA Sequencing Market, by Product, 2023-2030 (USD Million)
    192. Million)
    193. (USD Million)
    194. 2030 (USD Million)
    195. Region, 2023-2030 (USD Million)
    196. by Types, 2023-2030 (USD Million)
    197. by Product, 2023-2030 (USD Million)
    198. Market, by Technology, 2023-2030 (USD Million)
    199. Sequencing Market, by Application, 2023-2030 (USD Million)
    200. Europe: DNA Sequencing Market, by End-User, 2023-2030 (USD Million)
    201. Eastern Europe: DNA Sequencing Market, by Region, 2023-2030 (USD Million)
    202. Asia-Pacific: DNA Sequencing Market, by Types, 2023-2030 (USD Million)
    203. Asia-Pacific: DNA Sequencing Market, by Product, 2023-2030 (USD Million)
    204. Asia-Pacific: DNA Sequencing Market, by Technology, 2023-2030 (USD Million)
    205. (USD Million)
    206. Product, 2023-2030 (USD Million)
    207. Market, by Technology, 2023-2030 (USD Million)
    208. DNA Sequencing Market, by Application, 2023-2030 (USD Million)
    209. East & Africa: DNA Sequencing Market, by End-User, 2023-2030 (USD Million)
    210. (USD Million)
    211. Process
    212. Segmentation Market Dynamics for Global DNA Sequencing Market
    213. DNA Sequencing Market Share, by Types, 2020 (%)
    214. Market Share, by Product, 2020 (%)
    215. by Technology, 2020 (%)
    216. North America: DNA Sequencing Market Share, by Country, 2020 (%)
    217. Europe: DNA Sequencing Market Share, by Country, 2020 (%)
    218. DNA Sequencing Market Share, by Country, 2020 (%)
    219. Africa: DNA Sequencing Market Share, by Country, 2020 (%)
    220. DNA Sequencing Market: Company Share Analysis, 2020 (%)
    221. Key Financials
    222. Elmer: Geographical Revenue
    223. Geographical Revenue
    224. AG: Segmental Revenue
    225. Illumina: Key Financials
    226. Illumina: Geographical Revenue
    227. Financials
    228. Agilent Technologies Inc.: Geographical Revenue
    229. Key Financials
    230. Genia corporation: Geographical Revenue
    231. Key Financials
    232. Philips N.V.: Key Financials
    233. Revenue
    234. Pacific Biosciences: Key Financials
    235. Revenue
    236. Johnson & Johnson: Key Financials
    237. Revenue
    238. Deep Genomics, Inc.: Key Financials
    239. Revenue
    240. Life Technologies: Key Financials
    241. Financials
    242. Geographical Revenue
    243. Segmental Revenue
    244. Thorne Biosciences: Key Financials
    245. Revenue
    246. General Electric Company: Key Financials
    247. Segmental Revenue
    248. GmbH: Segmental Revenue
    249. Revenue
    250. Coulter: Key Financials
    251. Beckman Coulter: Geographical Revenue
    252. Geographical Revenue

    DNA Sequencing System Market Segmentation

    DNA Sequencing System Market Product Outlook (USD Billion, 2019-2030)

    • Consumable
    • Instrument
    • Service

    DNA Sequencing System Market Application Outlook (USD Billion, 2019-2030)

    • Diagnostics
    • Biomarkers & Cancer
    • Reproductive Health
    • Personalized Medicine
    • Forensics

    DNA Sequencing System Market Technology Outlook (USD Billion, 2019-2030)

    • Semiconductor Sequencing
    • Sequencing by Ligation
    • Pyrosequencing

    DNA Sequencing System Market End-User Outlook (USD Billion, 2019-2030)

    • Academic & Government Research Institutes
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Hospitals & Clinics

    DNA Sequencing System Market Regional Outlook (USD Billion, 2019-2030)

    • North America Outlook (USD Billion, 2019-2030)

      • North America DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • North America DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • North America DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • North America DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • US Outlook (USD Billion, 2019-2030)

      • US DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • US DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • US DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • US DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • CANADA Outlook (USD Billion, 2019-2030)

      • CANADA DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • CANADA DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • CANADA DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • CANADA DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

    • Europe Outlook (USD Billion, 2019-2030)

      • Europe DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Europe DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Europe DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Europe DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • Germany Outlook (USD Billion, 2019-2030)

      • Germany DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Germany DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Germany DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Germany DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • France Outlook (USD Billion, 2019-2030)

      • France DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • France DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • France DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • France DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • UK Outlook (USD Billion, 2019-2030)

      • UK DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • UK DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • UK DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • UK DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • ITALY Outlook (USD Billion, 2019-2030)

      • ITALY DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • ITALY DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • ITALY DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • ITALY DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • SPAIN Outlook (USD Billion, 2019-2030)

      • Spain DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Spain DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Spain DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Spain DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • Rest Of Europe Outlook (USD Billion, 2019-2030)

      • Rest Of Europe DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • REST OF EUROPE DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • REST OF EUROPE DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • REST OF EUROPE DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

    • Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Asia-Pacific DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Asia-Pacific DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Asia-Pacific DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Asia-Pacific DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • China Outlook (USD Billion, 2019-2030)

      • China DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • China DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • China DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • China DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • Japan Outlook (USD Billion, 2019-2030)

      • Japan DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Japan DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Japan DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Japan DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • India Outlook (USD Billion, 2019-2030)

      • India DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • India DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • India DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • India DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • Australia Outlook (USD Billion, 2019-2030)

      • Australia DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Australia DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Australia DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Australia DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)

      • Rest of Asia-Pacific DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Rest of Asia-Pacific DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Rest of Asia-Pacific DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Rest of Asia-Pacific DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

    • Rest of the World Outlook (USD Billion, 2019-2030)

      • Rest of the World DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Rest of the World DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Rest of the World DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Rest of the World DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • Middle East Outlook (USD Billion, 2019-2030)

      • Middle East DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Middle East DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Middle East DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Middle East DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • Africa Outlook (USD Billion, 2019-2030)

      • Africa DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Africa DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Africa DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Africa DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics

      • Latin America Outlook (USD Billion, 2019-2030)

      • Latin America DNA Sequencing System Market by Product
        • Consumable
        • Instrument
        • Service
      • Latin America DNA Sequencing System Market by Application
        • Diagnostics
        • Biomarkers & Cancer
        • Reproductive Health
        • Personalized Medicine
        • Forensics
      • Latin America DNA Sequencing System Market by Technology
        • Semiconductor Sequencing
        • Sequencing by Ligation
        • Pyrosequencing
      • Latin America DNA Sequencing System Market by End-User
        • Academic & Government Research Institutes
        • Pharmaceutical Companies
        • Biotechnology Companies
        • Hospitals & Clinics
    DNA Sequencing Market Research Report - Forecast to 2032 Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027